Indian cardiology market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2024-2031). The key factors influencing the market growth of Indian cardiology are increasing incidence of cardiovascular diseases, frequent technology updates in cardiovascular devices, reforms in the pricing and government policies which led to the availability of devices, entry of Indian manufacturers in the global markets, and enhanced investment in R&D and collaboration in manufacturing.
Browse the full report description of “Indian Cardiology Market Size, Share & Trends Analysis Report by Cardiology Device Types (Cardiovascular Stents, Cardiovascular Catheters, Cardiac Rhythm Management Devices, and Cardiovascular Assistive Devices), by Drugs Types (Antithrombotic Drugs, Antidyslipidemic Drugs, Antihypertensive Drugs, and Anti-Stroke Drugs) by Surgery Types (Coronary Artery Bypass Grafting, Transmyocardial Laser Revascularization, Heart Valve Repair, Cardiac Resynchronization Therapy (CRT), Aneurysm Repair, and Heart Transplant) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/indian-cardiology-market-size
Recent Developments
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Cardiology Device Type
o By Drugs Type
o By Surgery Type
• Competitive Landscape- Boston Scientific Corp., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., and Medtronic PLC among others.
Key questions addressed by the report.
Indian Cardiology Market Report Segment
By Cardiology Device Type
By Drugs Type
By Surgery Types
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-cardiology-market-size